Results 291 to 300 of about 2,610,836 (314)
Some of the next articles are maybe not open access.
Breast Disease, 2001
Ductal carcinoma in situ (DCIS) has become a predominant pathologic entity with the broad implementation of screening mammography. In the premammographic era, it represented less than 10% of all breast cancers. Although it now occupies as much as 30% of contemporary series, it remains a controversial subject of debate in terms of its management.
openaire +3 more sources
Ductal carcinoma in situ (DCIS) has become a predominant pathologic entity with the broad implementation of screening mammography. In the premammographic era, it represented less than 10% of all breast cancers. Although it now occupies as much as 30% of contemporary series, it remains a controversial subject of debate in terms of its management.
openaire +3 more sources
2016
Ductal carcinoma in situ (DCIS) is defined as abnormally proliferating malignant cells confined to the breast milk ducts by the basement membrane. The prognosis of DCIS with microinvasion (DCISM) is intermediate between those of DCIS and invasive ductal cancer.
+7 more sources
Ductal carcinoma in situ (DCIS) is defined as abnormally proliferating malignant cells confined to the breast milk ducts by the basement membrane. The prognosis of DCIS with microinvasion (DCISM) is intermediate between those of DCIS and invasive ductal cancer.
+7 more sources
Hematology/Oncology Clinics of North America
In breast cancer (BC) pathogenesis models, normal cells acquire somatic mutations and there is a stepwise progression from high-risk lesions and ductal carcinoma in situ to invasive cancer. The precancer biology of mammary tissue warrants better characterization to understand how different BC subtypes emerge.
Brittany L, Bychkovsky +4 more
openaire +2 more sources
In breast cancer (BC) pathogenesis models, normal cells acquire somatic mutations and there is a stepwise progression from high-risk lesions and ductal carcinoma in situ to invasive cancer. The precancer biology of mammary tissue warrants better characterization to understand how different BC subtypes emerge.
Brittany L, Bychkovsky +4 more
openaire +2 more sources
MANAGEMENT OF DUCTAL CARCINOMA IN SITU
Surgical Clinics of North America, 1999The dramatic increase in the incidence of ductal carcinoma in situ (DCIS) of the breast has made it imperative for all clinicians to develop a better understanding of this disease. Although this preinvasive form of breast cancer is not life-threatening, treatment options may include mastectomy, breast-conserving surgery, radiotherapy, or tamoxifen ...
Laura J. Esserman, E. Shelley Hwang
openaire +3 more sources
Management of ductal carcinoma in situ
Seminars in Surgical Oncology, 1996The management of ductal carcinoma in situ (DCIS) is one of the most controversial topics in the treatment of breast cancer. With the introduction and utilization of screening mammography, clinically occult or microscopic DCIS has become the most frequent presentation of this disease.
openaire +3 more sources
Ductal Carcinoma in Situ of the Breast
Annals of Internal Medicine, 1997The increasing incidence and biological heterogeneity of ductal carcinoma in situ (DCIS) of the breast have made the management of this entity challenging and controversial. This paper reviews data on the natural history of the disease and results obtained with various management approaches.Computerized MEDLINE search of articles related to DCIS ...
Lynn C. Hartmann +5 more
openaire +3 more sources
2014
Ductal carcinoma in situ is a malignant proliferation of epithelial cells within the ducts with no invasion. DCIS (ductal carcinoma in situ) is a heterogenous group of lesions that have very different morphology, biology, and clinical behavior. It is considered to be a true precursor of invasive disease although not all DCIS progress to become invasive
openaire +4 more sources
Ductal carcinoma in situ is a malignant proliferation of epithelial cells within the ducts with no invasion. DCIS (ductal carcinoma in situ) is a heterogenous group of lesions that have very different morphology, biology, and clinical behavior. It is considered to be a true precursor of invasive disease although not all DCIS progress to become invasive
openaire +4 more sources
Radiotherapy for Ductal Carcinoma In Situ
Clinical Oncology, 2006The introduction of breast screening mammography has led to an increase in the diagnosis of ductal carcinoma in situ (DCIS). Mastectomy gives high rates of local control. However, most cases are suitable for local excision. The aim of this article is to review the role of radiotherapy in the treatment of DCIS after breast conserving surgery.A review of
N.J. Bundred, Julian Adlard
openaire +3 more sources
Ductal carcinoma in situ with microinvasion
The American Journal of Surgery, 2003Ductal carcinoma in situ (DCIS) accounts for nearly 20% of new breast cancer diagnoses and ductal carcinoma in situ with microinvasion (DCIS-MI) is found in 5% to 10% of DCIS. Controversy exists regarding the appropriate local treatment as well as whether or not examination of the axilla should be performed either by sentinel lymph node biopsy (SLNB ...
Tara L Adamovich, Rache M. Simmons
openaire +3 more sources
In Situ Ductal Carcinoma of the Breast
JAMA: The Journal of the American Medical Association, 1962IN RECENT LITERATURE emanating from the Mayo Clinio, a study of preinvasive duct carcinoma of the breast was presented. This article is being written to add to the total number of cases in the literature of this rarely found condition, to offer what we consider to be an important presenting symritom, and to plead for more attention to symptoms of pain ...
Walter L. Miller +2 more
openaire +3 more sources